May 5, 2010 / 12:12 PM / in 8 years

UPDATE 1-NxStage posts narrower-than-expected quarterly loss

* Q1 loss/shr $0.19 vs est loss/shr $0.20

* Net revenue up 20 pct

May 5 (Reuters) - Dialysis products maker NxStage Medical Inc (NXTM.O) posted a narrower-than-expected quarterly loss, helped by strong performance across its home and critical care segments.

For the first quarter, the company posted a net loss of $9.0 million, or 19 cents a share, compared with a net loss of $12.2 million, or 26 cents a share, in the year-ago period.

Analysts were expecting a loss of 20 cents a share, according to Thomson Reuters I/B/E/S.

Total revenue rose 20 percent to $40.4 million, beating analysts’ estimates of $38.81 million. Its home market grew 33 percent while its critical care segment grew 36 percent.

    For the alerts, please click on [ID:nASA00BF1]

    Shares of NxStage closed at $12.89 Tuesday on Nasdaq. (Reporting by Jennifer Robin Raj in Bangalore; Editing by Ratul Ray Chaudhuri)

    0 : 0
    • narrow-browser-and-phone
    • medium-browser-and-portrait-tablet
    • landscape-tablet
    • medium-wide-browser
    • wide-browser-and-larger
    • medium-browser-and-landscape-tablet
    • medium-wide-browser-and-larger
    • above-phone
    • portrait-tablet-and-above
    • above-portrait-tablet
    • landscape-tablet-and-above
    • landscape-tablet-and-medium-wide-browser
    • portrait-tablet-and-below
    • landscape-tablet-and-below